A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 1683
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : BChE
Long Form : butyrylcholinesterase
No. Year Title Co-occurring Abbreviation
2021 21-Day dermal exposure to aircraft engine oils: effects on esterase activities in brain and liver tissues, blood, plasma, and clinical chemistry parameters for Sprague Dawley rats. AChE
2021 A molecular approach to rationally constructing specific fluorogenic substrates for the detection of acetylcholinesterase activity in live cells, mice brains and tissues. AChE, CE
2021 A Smartphone Camera Colorimetric Assay of Acetylcholinesterase and Butyrylcholinesterase Activity. AChE
2021 Acetylcholinesterase and monoamine oxidase-B inhibitory activities by ellagic acid derivatives isolated from Castanopsis cuspidata var. sieboldii. AChE, BACE1, MAOs
2021 Acetylcholinesterase inhibitory activity of extract and fractions from the root of Rauvolfia serpentina(L.) Bth.ex Kurz. AChE, AD, VLC
2021 Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment. AChE, AD
2021 Amygdalus spinosissima root extract enhanced scopolamine-induced learning and memory impairment in mice. AChE
2021 AND-Logic Strategy for Accurate Analysis of Alzheimer's Disease via Fluorescent Probe Lighted Up by Two Specific Biomarkers. AD, ROSs
2021 Anti-cholinesterase and Neuroprotective Activities of Sweet and Bitter Apricot Kernels (Prunus armeniaca L.). AChE, ChE, ITM
10  2021 Appraisal of organic extracts and isolated compounds of Azadirachta indica for in-vitro antioxidant, acetylcholinesterase and butyrylcholinesterase inhibitory activity. AChE
11  2021 Attenuation of spatial memory in 5xFAD mice by targeting cholinesterases, oxidative stress and inflammatory signaling using 2-(hydroxyl-(2-nitrophenyl)methyl)cyclopentanone. 2NCP, AChE, AD, DPPH, EPM, FC, GST, HC, MWM, NF-kappaB
12  2021 BACE1 and cholinesterase inhibitory activities of compounds from Cajanus cajan and Citrus reticulata: an in silico study. AChE, AD, BACE1, ChE
13  2021 Bio-Potency and Molecular Docking Studies of Isolated Compounds from Grewia optiva J.R. Drumm. ex Burret. AChE
14  2021 Biological Insights and NMR Metabolic Profiling of Different Extracts of Spermacoce verticillata (L.) G. Mey. AChE
15  2021 Biologically active phthalocyanine metal complexes: Preparation, evaluation of α-glycosidase and anticholinesterase enzyme inhibition activities, and molecular docking studies. AChE, alpha-Gly, ChE
16  2021 Butyrylcholinesterase as a perioperative complication marker in patients after transcatheter aortic valve implantation: a prospective observational study. AChE, TAVI
17  2021 Butyrylcholinesterase nanodepots with enhanced prophylactic and therapeutic performance for acute organophosphorus poisoning management. AChE, AOPP, nBChE
18  2021 Butyrylcholinesterase: An economical marker of disease activity in oral squamous cell carcinoma before and after therapy. OSCC
19  2021 Can use of hydroxychloroquine and azithromycin as a treatment of COVID-19 affect aquatic wildlife? A study conducted with neotropical tadpole. AChE, AZT, HCQ
20  2021 Changes in choline and cholinesterase in saliva of dogs with parvovirus infection. Ch, CP, CRP, WBC
21  2021 Changes in saliva analytes during pregnancy, farrowing and lactation in sows: A sialochemistry approach. ADA1, ALP, AOPP, AST, CK, GGT, Hp, LDH, LIP
22  2021 Chemical Composition, Antioxidant and Enzyme Inhibitory Activities of Onosma bourgaei and Onosma trachytricha and in Silico Molecular Docking Analysis of Dominant Compounds. AChE, MeOH
23  2021 Chemical similarity assisted search for acetylcholinesterase inhibitors: Molecular modeling and evaluation of their neuroprotective properties. AChE, AD
24  2021 Cholinesterases, carbonic anhydrase inhibitory properties and in silico studies of novel substituted benzylamines derived from dihydrochalcones. AChE, IFD
25  2021 Chromenone Derivatives as Monoamine Oxidase Inhibitors from Marine-Derived MAR4 Clade Streptomyces sp. CNQ-031. AChE, MAOs, SI
26  2021 Comparative effects of berberine and piperine on the neuroprotective potential of neostigmine. AChE, AD, DPPH, LPO, MAO, NDDs, NO, SNP
27  2021 Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches. AChE, AUAC, BEDROC, CADD, EF, MAO, ROC
28  2021 Design and synthesis of garlic-related unsymmetrical thiosulfonates as potential Alzheimer's disease therapeutics: In vitro and in silico study. AChE
29  2021 Determination of butyrylcholinesterase activity based on thiamine luminescence modulated by MnO2 nanosheets. BTCh, TC, TH
30  2021 Determination of K869, a Novel Oxime Reactivator of Acetylcholinesterase, in Rat Body Fluids and Tissues by Liquid-Chromatography Methods: Pharmacokinetic Study. AChE
31  2021 Discovery of Natural Inhibitors of Cholinesterases from Hydrangea: In Vitro and In Silico Approaches. AChE, AD, HGP, PAS, TC
32  2021 Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties. AChE, AD, CNSL
33  2021 Discovery, biological evaluation and molecular dynamic simulations of butyrylcholinesterase inhibitors through structure-based pharmacophore virtual screening. AD
34  2021 Effects of berberine on cholinesterases and monoamine oxidase activities, and antioxidant status in the brain of streptozotocin (STZ)-induced diabetic rats. AChE, Ber, GPx, MAO, MDA, SOD, STZ
35  2021 Enhancement of Fear Extinction Memory and Resistance to Age-Related Cognitive Decline in Butyrylcholinesterase Knockout Mice and (R)-Bambuterol Treated Mice. AD, DESI-MSI, KO, PTSD, WT
36  2021 Enzyme inhibitory function and phytochemical profile of Inula discoidea using in vitro and in silico methods. AChE, alpha-Gly, GST
37  2021 Evaluation of Antioxidant and Enzyme Inhibition Properties of Croton hirtus L'Hér. Extracts Obtained with Different Solvents. ABTS, AChE, APCI, DPPH, FRAP
38  2021 Evaluation of different almond (Terminalia catappa) extracts against oxidative stress induced by cyclosporine in brain and liver of rats. AChE, ALP, AST, CsA, NO, TBARS
39  2021 Evaluation of the effect of high protein supply on diaphragm atrophy in critically ill patients receiving prolonged mechanical ventilation. INT, MV, SNT
40  2021 Evidence of exposure to organophosphorus toxicants by detection of the propionylated butyrylcholinesterase-derived nonapeptide-adduct as a novel biomarker. HSA, NP, OP, OPCW
41  2021 Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors. AChE, HRMS
42  2021 Fluorescent Determination of Butyrylcholinesterase Activity and Its Application in Biological Imaging and Pesticide Residue Detection. AChE, AD, LOD
43  2021 Genetic Association of Butyrylcholinesterase with Major Depressive Disorder. ARMS-PCR, MDD, PCR-RFLP
44  2021 Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection. ACh, AD
45  2021 Identification and Study of Biomarkers from Novichok-Inhibited Butyrylcholinesterase in Human Plasma. ---
46  2021 Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity. AChE, BACE1
47  2021 Identification of Butyrylcholinesterase and Monoamine Oxidase B Targeted Ligands and their Putative Application in Alzheimer's Treatment: A Computational Strategy. AD, GSK-3, MAO-B, MAOA
48  2021 Identification of Compounds for Butyrylcholinesterase Inhibition. ACh, AChE, qHTS
49  2021 Identification of plant-based multitargeted leads for Alzheimer's disease: In-vitro and in-vivo validation of Woodfordia fruticosa (L.) Kurz. AChE, AD, BACE1, CG
50  2021 Immobilization of transgenic plant cells towards bioprinting for production of a recombinant biodefense agent. LAP, PEGTA
51  2021 In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase. AChE
52  2021 In vitro age-related differences in rats to organophosphates. AChE, CaE, IC50s, OPs
53  2021 In vitro cholinesterase inhibitory action of Cannabis sativa L. Cannabaceae and in silico study of its selected phytocompounds. AChE, BA, PAS
54  2021 In Vitro Enzymatic and Kinetic Studies, and In Silico Drug-Receptor Interactions, and Drug-Like Profiling of the 5-Styrylbenzamide Derivatives as Potential Cholinesterase and β-Secretase Inhibitors with Antioxidant Properties. AChE, LPS, ROS
55  2021 In vitro examination of anti-parasitic, anti-Alzheimer, insecticidal and cytotoxic potential of Ajuga bracteosa Wallich leaves extracts. AChE, CH, EA, EL, NH
56  2021 Inducing new bioactive metabolites production from coculture of Pestalotiopsis sp. and Penicillium bialowiezense. GUS
57  2021 Interaction of Exogenous Butyrylcholinesterase with β-Amyloid Plaques in 5XFAD/Butyrylcholinesterase-Knockout Mouse Brain. AD
58  2021 Isolation, Characterization, and Medicinal Potential of Polysaccharides of Morchella esculenta. AChE
59  2021 Liver Enzymes Correlate With Metabolic Syndrome, Inflammation, and Endothelial Dysfunction in Prepubertal Children With Obesity. CRP, MetS, NAFLD, sICAM-1
60  2021 Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease. AD, BBB, CT, PET, WT
61  2021 Measuring butyrylcholinesterase activity and hematological parameters in farmers exposed to pesticides: a case and control study from Morocco. Hb
62  2021 microRNA-155 Expression and Butyrylcholinesterase Activity in the Liver Tissue of Mice Infected with Toxoplasma gondii (Avirulent and Virulent Strains). miRNA-155, p.i
63  2021 Microwave-Assisted Synthesis of (Piperidin-1-yl)quinolin-3-yl)methylene)hydrazinecarbothioamides as Potent Inhibitors of Cholinesterases: A Biochemical and In Silico Approach. AChE, AD, SAR
64  2021 Modulatory effect of pigeon pea-wheat biscuits on lipid profile, lipid peroxidation level, α-glucosidase, and butyrylcholinesterase activities in type-2 diabetic patients. ALP, DP, PP
65  2021 Molecular cloning and characterization of an atypical butyrylcholinesterase-like protein in zebrafish. 2-AG, ACh, OP
66  2021 Monophosphoramide derivatives: synthesis and crystal structure, theoretical and experimental studies of their biological effects. Ace, AChE
67  2021 Multifarious Functions of Butyrylcholinesterase in Neuroblastoma: Impact of BCHE Deletion on the Neuroblastoma Growth In Vitro and In Vivo. WT
68  2021 Multivalent butyrylcholinesterase inhibitor discovered by exploiting dynamic combinatorial chemistry. AChE, DCL
69  2021 Neuroprotective Effect of Terpenoids Recovered from Olive Oil By-Products. AChE, GC-QTOF-MS, LOX, SFE
70  2021 Neuroprotective Studies on Polygonum hydropiper L. Essential Oils Using Transgenic Animal Models. AChE, ADs, APP, DPPH, PCR, SWM
71  2021 New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors. AChE
72  2021 Non-quaternary oximes detoxify nerve agents and reactivate nerve agent-inhibited human butyrylcholinesterase. AChE, BBB, EMP-MeCyC, HTS, NA, OP
73  2021 Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids. AChE, CAS, ChE, PAS
74  2021 Organophosphate detoxification by membrane-engineered red blood cells. OPNAs, RBC, RBCs
75  2021 Outlining In Vitro and In Silico Cholinesterase Inhibitory Activity of Twenty-Four Natural Products of Various Chemical Classes: Smilagenin, Kokusaginine, and Methyl Rosmarinate as Emboldening Inhibitors. AChE, AD, ChE, PAS
76  2021 Permeability of Hypogymnia physodes Extract Component-Physodic Acid through the Blood-Brain Barrier as an Important Argument for Its Anticancer and Neuroprotective Activity within the Central Nervous System. AChE, COX-2, HP extract, PAMPA-BBB
77  2021 Pharmacological evaluation and in-silico modeling study of compounds isolated from Ziziphus oxyphylla. AChE
78  2021 Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents. AChE, AD, ChE
79  2021 Phytochemical Analysis and Evaluation of Biological Activity of Lawsonia inermis Seeds Related to Alzheimer's Disease. AChE, AD, ITM
80  2021 Phytochemical Composition, Antioxidant, and Enzyme Inhibition Activities of Methanolic Extracts of Two Endemic Onosma Species. AChE, CUPRAC, DPPH, FRAP
81  2021 Profiling the annual change of the neurobiological and antioxidant effects of five Origanum species in correlation with their phytochemical composition. AChE
82  2021 Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches. AChE, AD, FT-IR
83  2021 Quinuclidine-Based Carbamates as Potential CNS Active Compounds. AChE, BBB, CNS
84  2021 Ratiometric sensing of butyrylcholinesterase activity based on the MnO2 nanosheet-modulated fluorescence of sulfur quantum dots and o-phenylenediamine. NS, OPD, S dots
85  2021 Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes. AChE, OBD, OPs
86  2021 Release of protein-bound nerve agents by excess fluoride from whole blood: GC-MS/MS method development, validation, and application to a real-life denatured blood sample. GD, IMPA
87  2021 RP-UHPLC-MS Chemical Profiling, Biological and In Silico Docking Studies to Unravel the Therapeutic Potential of Heliotropium crispum Desf. as a Novel Source of Neuroprotective Bioactive Compounds. AChE, RP-UHPLC-MS
88  2021 Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse Model. AD, MTDLs
89  2021 Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease. AChE, AD, CNSL, MTDLs
90  2021 Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer's disease. AChE, AD, MTDLs, MWM
91  2021 Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase. AD
92  2021 Synthesis and Initial Characterization of a Selective, Pseudo-irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer. AD, PET
93  2021 Synthesis of novel 1,2,3 triazole derivatives and assessment of their potential cholinesterases, glutathione S-transferase enzymes inhibitory properties: An in vitro and in silico study. AChE, AD, GST
94  2021 Synthesis of novel sulfonamides with anti-Alzheimer and antioxidant capacities. AChE
95  2021 Synthesis, Biological Evaluation, and In Silico Studies of New Acetylcholinesterase Inhibitors Based on Quinoxaline Scaffold. AChE, BBB, CAS, PAS
96  2021 Synthesis, Characterization, and Inhibition Study of Novel Substituted Phenylureido Sulfaguanidine Derivatives as α-Glycosidase and Cholinesterase Inhibitors. AChE, AD, alpha-Gly, DM
97  2021 Synthesis, Spectroscopic Analysis, and in Vitro/in Silico Biological Studies of Novel Piperidine Derivatives Heterocyclic Schiff-Mannich Base Compounds. AChE, GST
98  2021 Systematic In Silico Design, Synthesis, and Biological Studies of Some Novel 1,4-Benzoquinone Derivatives for the Prospective Management of Cognitive Decline. AChE, QSSR
99  2021 The functional potential of nine Allium species related to their untargeted phytochemical characterization, antioxidant capacity and enzyme inhibitory ability. AChE
100  2021 The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer's Disease Pathogenesis. AD, NFTs